Krystal Biotech (KRYS) Receives FDA Approval for VYJUVEK
FREE Breaking News Alerts from StreetInsider.com!
- Tech selloff weighs down Wall Street as bond yields climb
- Baidu slips as Q2 results miss estimates despite growth in AI cloud business
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
- Home Depot beats estimates, reaffirms fiscal 2026 guidance
- Citi says positioning risk is shifting from short squeezes to profit-taking
- Wall Street indexes slip as oil prices rise, retail results awaited
- Tech selloff weighs down Wall Street as bond yields climb
- Micron rises as White House presses Apple to avoid Chinese memory chips
- BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
- Francisco Partners to acquire Weave Communications for $650M
Krystal Biotech (KRYS) to Resume Trading at 2:20 p.m.
May 19, 2023 2:04 PM EDT(Updated - May 19, 2023 2:04 PM EDT)
Krystal Biotech (NASDAQ: KRYS) to Resume Trading at 2:20 p.m.
... More